Profil
Thomas Fuchs is currently an Independent Director at GeneDx Holdings Corp.
since 2025.
Dr. Fuchs is also the Chief Artificial Intelligence Officer & Senior VP at Eli Lilly & Co. since 2024.
Dr. Fuchs holds a doctorate from the Swiss Federal Institute of Technology and a graduate degree from Graz University of Technology.
Aktive Positionen von Thomas Fuchs
| Unternehmen | Position | Beginn |
|---|---|---|
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 21.10.2024 |
| GENEDX HOLDINGS CORP. | Direktor/Vorstandsmitglied | 17.09.2025 |
Ausbildung von Thomas Fuchs
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graz University of Technology
Graz University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneDx Holdings Corp.
GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
















